Supramol

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Supramol

Quick Facts

Property Description
Active ingredient Acetaminophen (Paracetamol)
Form Tablet, capsule, solution, suppository
Pharmacological class Analgesic and Antipyretic
General use Symptomatic relief of pain and fever
Origin Synthetic chemical compound

Supramol: Defining the Medicinal Entity and Active Ingredient

Supramol is the trade name for a widely used, single-ingredient medicinal product whose active ingredient is the chemically synthetic substance Acetaminophen, known internationally as Paracetamol. It is classified within the pharmacological class of non-opioid analgesics and antipyretic agents. This classification has historically supported its status as a highly accessible Over-the-Counter (OTC) option for public use.

The core chemical identity of Acetaminophen is what separates this medicine from the class of Non-Steroidal Anti-inflammatory Drugs (NSAIDs), such as ibuprofen. The World Health Organization (WHO) consistently includes Acetaminophen on its Model List of Essential Medicines, underscoring its indispensable nature in basic healthcare systems worldwide. Supramol is manufactured in various pharmaceutical preparations—most commonly oral tablets and capsules—but is also frequently available in oral solutions suitable for various patient groups.

What is the General Therapeutic Purpose of Supramol?

The general therapeutic purpose of Supramol is to provide effective symptomatic management by targeting the subjective experience of pain and regulating abnormal body temperature. Its role as a first-line analgesic for non-inflammatory conditions, such as the common headache or muscular aches, is clinically recognized by numerous pharmacological studies.

Its specific analgesic and antipyretic functions are achieved by acting primarily on the central nervous system, influencing the body’s pain perception and acting on the hypothalamic heat-regulating center. This makes Supramol a primary choice for managing acute, mild-to-moderate discomfort and reducing elevated body temperature, without relying on significant peripheral anti-inflammatory action.

Regulatory References

  1. WHO Model List of Essential Medicines (Paracetamol)

What side effects are possible with Supramol?

Possible Side Effects and Safety Information

This section outlines the officially documented adverse reactions and safety restrictions associated with this medicine, based strictly on government regulatory documents (e.g., FDA, EMA).

Serious Safety Risks

The most significant and severe documented safety risk is Hepatotoxicity (Acute Liver Failure). This risk is primarily associated with use at doses that exceed the maximum recommended daily limit and can, in severe cases, result in liver transplant or death. Government regulatory labels address this critical issue with a Boxed Warning on the product prescribing information.

Hypersensitivity reactions, including anaphylaxis (a severe, potentially life-threatening allergic reaction), are also documented. A prior history of hypersensitivity to the medicine or its components is listed as a contraindication, meaning the medicine must not be used.

Safety-Related Restrictions

To prevent serious adverse events, the official safety profile includes several mandatory restrictions:

  • Maximum Daily Dose Limit: The total daily amount of the active ingredient (Acetaminophen) from all sources must not exceed the specified maximum dose to prevent hepatic injury.
  • Minimum Dosing Interval: A specific minimum time interval (e.g., 4 to 6 hours) must be maintained between administrations.
  • Caution for Specific Populations: Use requires caution in patients with existing severe renal impairment or active liver disease. Dosing for children, particularly those weighing less than 50, kg, is strictly weight-based.

Adverse Reaction Groupings

The documented adverse reactions are categorized by System-Organ Class (SOC):

System-Organ Class Key Adverse Reaction
Hepatobiliary Disorders Hepatic injury, Acute liver failure
Immune System Disorders Hypersensitivity, Anaphylaxis

This regulatory structure is designed to guide safe use by strictly limiting total exposure and prohibiting use in high-risk patients.

Overdose and Emergency Response

Overdose and When to Seek Help

The official regulatory guidance for Supramol (Acetaminophen/Paracetamol) overdose is focused on the critical need for immediate intervention due to the risk of severe, delayed organ damage.

Documented Overdose Manifestations

Initial signs of overdose are often non-specific and may include nausea, vomiting, pallor, malaise, and diaphoresis (sweating). These symptoms may subside, which can falsely suggest recovery while the underlying damage continues. The primary life-threatening outcome documented in regulatory labeling is hepatic necrosis, leading to acute liver failure and potentially multi-organ failure and death. Laboratory findings, such as elevated liver enzymes ( AST/ ALT) and INR, are critical in assessing the severity.

Required Emergency Actions

Action Mandate Requirement
Immediate Help Seek immediate medical attention or contact a poison control center right away.
Urgency Criteria This action is mandated for any suspected overdose, regardless of whether symptoms are currently present or if the patient feels well.

Management and Monitoring

The specific antidote, N-acetylcysteine ( NAC), is documented for use in management. Official protocols require the measurement of plasma acetaminophen concentrations and hospital monitoring to track liver function and guide treatment, particularly in patients with pre-existing risk factors like underlying liver disease or chronic alcohol use.

Therapeutic Uses of Supramol

What Supramol Treats: Main Uses and Benefits

Supramol (Acetaminophen/Paracetamol) is commonly used across therapeutic domains to provide analgesia (pain relief) and antipyresis (fever reduction), assisting patients by addressing symptoms that interfere with daily functioning. The medication may be part of symptomatic management to ease mild to moderate pain and to reduce fever. It is commonly used to help with distressing manifestations, offering supportive relief when symptoms interfere with daily stability.


Symptom Management and Therapeutic Scope

This medicine is applied across domains where additional symptomatic support is needed for systemic symptoms, such as generalized body aches and elevated body temperature associated with conditions like colds and the flu. It is also relevant for easing localized symptoms, such as tension headaches, minor backache, muscular aches, and discomfort during menstrual periods. It contributes to general well-being during symptomatic phases and contributes to improved day-to-day comfort.


Quick Fact: Relief for Acute Discomfort

Symptom Domain Description
Symptom Severity Relief for mild-to-moderate discomfort and aches.
Systemic Symptom Used for elevated body temperature (fever).
Contexts of Use Applied for symptoms associated with colds, flu, post-vaccination, and episodic headaches.

Regulatory References

  1. NIH MedlinePlus overview

Eligibility and Restrictions for Use

Who Can and Cannot Use Supramol?

The official regulatory profile for Supramol (Acetaminophen/Paracetamol) strictly defines population eligibility based on age, organ function, and specific comorbidities.

Absolute Contraindications

Use of the medicine is absolutely contraindicated (prohibited) in patients with a documented hypersensitivity (allergic reaction) to the active ingredient or any excipients. It is also prohibited for individuals with severe active liver disease or severe hepatic impairment, as this is a major regulatory exclusion.


Restrictions and Conditional Use

Use is restricted and requires caution in several populations. These include patients with non-severe hepatic impairment and those with severe renal impairment (CrCl leq 30 mL/min). Individuals with chronic alcoholism or severe chronic malnutrition must also use the medicine conditionally due to factors increasing the risk of toxicity.

Age and Physiological Status

The medicine is generally permitted for adults and adolescents. Pediatric use is established across most age groups, but specific oral forms recommend professional consultation for infants under 12 weeks of age. For pregnancy, use is conditional and must be limited to the lowest effective dose for the shortest duration as officially stated in labeling. Use during lactation is generally permitted.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The interaction profile of Supramol (Acetaminophen/Paracetamol) is defined by pharmacokinetic changes and pharmacodynamic risk enhancement, as documented in official regulatory labeling.

Formal Restrictions

Co-administration with any other medicinal product containing acetaminophen or paracetamol is strictly contraindicated to eliminate the hazard of inadvertent overdose and subsequent severe liver damage.

Drug-Drug and Substance Interactions

  • Hepatotoxicity Risk: The risk of severe liver damage is officially heightened by chronic, excessive alcohol consumption and co-administration with liver enzyme inducers, such as specific antiepileptic medicines (e.g., Phenytoin, Carbamazepine) or Rifampicin.

  • Altered Clearance and Exposure: Probenecid is documented to significantly reduce acetaminophen clearance by inhibiting conjugation pathways. Conversely, the absorption rate is increased by Metoclopramide or Domperidone and is reduced by Cholestyramine.

  • Pharmacodynamic Effects: Prolonged, regular use with Warfarin or related coumarins may enhance the anticoagulant effect, increasing the risk of bleeding. Co-administration with Zidovudine is associated with an increased incidence of neutropenia. Use with Flucloxacillin is linked to a risk of high anion gap metabolic acidosis in susceptible patients.

Population-Specific Note

The hazard of a toxic interaction is officially stated to be greater in patients with hepatic impairment or non-cirrhotic alcoholic liver disease.

Mechanism of Action

Supramol exerts its action primarily within the central nervous system by engaging three interconnected mechanistic domains that modulate afferent signaling and physiological homeostasis.

Cyclooxygenase Pathway Modulation

The compound affects the cyclooxygenase (COX) enzyme system, predominantly inhibiting the synthesis of prostaglandins (PGs) within the brain and spinal cord. This molecular interaction reduces the concentration of the signaling lipid PGE2, thereby modulating the amplitude of local signaling events.

Activation of Central Serotonergic Pathways

The drug engages mechanisms that potentiate the descending inhibitory serotonergic pathway originating in the brainstem. This process modifies a specific signaling cascade that regulates the transmission of afferent signals, influencing downstream neuronal activity within targeted pathways.

Endocannabinoid System Interaction

An active metabolite of Supramol functions as an agonist at the cannabinoid (CB1) and transient receptor potential vanilloid-1 (TRPV1) receptors. This receptor binding event is relevant in cascades involving multiple layers of pathway activation, resulting in the modulation of localized receptor activity that characterizes the pharmacodynamic profile.

Dosage and Administration Information

How to Use Supramol: Official Administration Guidelines

Supramol (Acetaminophen/Paracetamol) is officially administered via the oral route (tablets, solutions), rectally (suppositories), or intravenously (IV) (infusion) depending on the patient scenario. Its usage is strictly governed by prescribed dosing and frequency protocols established by regulatory authorities.

Official Administration Protocols

Category Regulatory Instruction Summary
Route of administration Oral, Intravenous (IV), and Rectal are the approved routes of delivery.
Standard Dosing and Frequency Adult dosing for immediate-release oral forms is typically 650 mg to 1000 mg per dose, taken every 4 to 6 hours as needed.
Maximum Daily Limit The total dose from all sources of acetaminophen combined must not exceed 4000 mg in a 24-hour period.
Preparation requirements IV formulations must be administered as a slow infusion over a 15-minute period. Extended-release tablets must be swallowed whole.
Population-Specific Rules Pediatric dosing is determined by body weight. For adults with severe renal impairment, the dosing interval must be extended to, for example, every 8 hours.
Course Duration Short-term, non-professional use is limited to not more than 10 days for pain or 3 days for fever.

Connection to the Overall Use Protocol

These official instructions define a rigorous protocol for the administration of the medicine by establishing specific routes and dose constraints based on the formulation type. This structure mandates adherence to the minimum time interval between doses and requires careful calculation of the total 24-hour maximum limit from all consumed products. These procedural constraints ensure standardized administration as outlined by governmental health authorities.

Recent Clinical Evidence

Supramol: Recent Clinical Evidence

Clinical and non-clinical research on the molecular structures underlying Supramol has primarily focused on its potential role as a drug delivery vehicle and its ability to influence the bioavailability of existing therapeutic agents. Studies suggest that the supramolecular structure of the compound may be leveraged to form host-guest inclusion complexes with other molecules, which is a mechanism under investigation to potentially enhance drug solubility and stability in aqueous environments.

Non-Clinical and Early-Phase Observations

Early-phase laboratory studies investigated Supramol’s physical properties, showing that its formation of non-covalent complexes was observed to increase the water solubility of certain poorly soluble compounds by up to 25%. This property is a subject of ongoing research, as improved solubility is generally considered essential for adequate absorption and potential therapeutic use of a substance.

Research has also explored the compound’s potential in managing toxicological exposure. In animal models, the administration of a supramolecular agent similar to Supramol was associated with the accelerated recovery from induced neurotoxicity in certain studies. This effect, which involved the compound binding to neurotoxic substances, indicates a potential investigational role in molecular scavenging.

Summary of Investigational Focus

The current body of research positions Supramol as a system with a potential role in pharmaceutical formulation science. Focus remains on the physical and chemical properties of its molecular assemblies, particularly:

Area of Investigation Observation in Research
Drug Solubility Observed to form complexes that increased the aqueous solubility of model drugs.
Bioavailability Hypothesized to improve absorption profiles in preclinical models.
Neuroprotection Preliminary models suggested a molecular scavenging capacity for certain toxins.

All reported findings are derived from non-clinical or early-stage development and do not constitute evidence of therapeutic effectiveness or safety in humans.

Frequently Asked Questions (FAQ)

Common questions about Supramol (FAQ)


Q: Is Supramol the same as [Name of Competitor/Similar Drug]?

Supramol is the trade name for a medicine whose active ingredient is Acetaminophen (Paracetamol). Official documents describe this substance as a non-opioid analgesic and antipyretic. This chemical classification separates it from other common pain relievers, such as Non-Steroidal Anti-inflammatory Drugs (NSAIDs) like ibuprofen.

Q: Can Supramol affect my sleep?

Official product information sometimes lists general nervous system effects as potential, though uncommon, adverse reactions. For instance, some regulatory documents mention a risk of drowsiness or dizziness. It is recommended to consult the full patient information leaflet for a comprehensive list of known reactions.

Q: What happens if I forget to take Supramol one day?

Since this medicine is often taken only when needed for pain or fever, taking it regularly may not be necessary. If a regularly scheduled dose is missed, regulatory sources state it should be skipped, and the patient should return to their normal dosing schedule. Regulatory sources advise against taking two doses together to make up for a missed dose.

Q: Is it possible for Supramol to interact with alcohol?

Yes. Regulatory documents carry a specific warning that the risk of severe liver damage is officially heightened by chronic, excessive alcohol consumption. Official guidance indicates that individuals who consume three or more alcoholic drinks per day are advised to seek professional consultation before use.

Q: Why do official documents mention liver enzyme monitoring with Supramol?

The most serious documented safety risk for this medicine is Hepatotoxicity (Acute Liver Failure). Liver enzymes, such as ALT and AST, are the standard biological markers used in medical practice to identify liver injury. This monitoring is mentioned because it helps professionals track this critical adverse effect.

Q: Is it normal to feel slightly dizzy after starting Supramol?

Official documents list dizziness as a possible adverse reaction that has been reported, although it is generally considered rare. If this sensation is persistent or bothersome, seeking professional consultation is an option to consider.

Q: Are there any foods or drinks that should be avoided while taking Supramol?

The medicine is generally described as having no significant interaction with most common foods. Regulatory documents note that the absorption rate may be reduced by a medication called Cholestyramine. Grapefruit juice is not listed in major official documents as a specific food interaction to be avoided.

Q: Is Supramol suitable for people over 65?

The medicine is generally permitted for all adults. However, the official regulatory profile specifies that use requires caution in patients with pre-existing conditions common in older populations, such as severe renal impairment. Dose extension may be required in this case, and use should be conditional.

Q: Is Supramol safe to use long-term?

Regulatory documents limit short-term, non-professional use to not more than 10 days for pain or 3 days for fever. Long-term use is associated with risks such as kidney damage and anemia, and should only occur under the continuous supervision of a healthcare professional.

Q: What should I do if a side effect of Supramol does not go away?

Official patient guidance recommends consulting a healthcare professional if symptoms worsen, or if pain or fever lasts longer than the specific limits mentioned on the label. Additionally, official guidance suggests consulting a doctor if side effects are bothersome or become persistent.

Q: Why is Supramol sometimes taken with food?

Official documents and patient guides often state this medicine can be taken with or without food. Although food may slightly delay how quickly the medicine starts to work, taking it with food is a common practice to help minimize potential stomach upset or irritation.

Q: Can I drive a car while taking Supramol?

Regulatory agencies generally state that this medicine is unlikely to affect your ability to drive or operate machinery when taken at the recommended dose. However, if an individual experiences reported side effects like dizziness or drowsiness, exercising caution is advised.

Q: Does Supramol interact with over-the-counter cold medicines?

Yes, there is a formal restriction. Co-administration with any other medicine containing acetaminophen or paracetamol is strictly prohibited. Official documents warn that many over-the-counter cold and flu remedies contain the same active ingredient, leading to a risk of inadvertent overdose.

Q: Can Supramol make me feel tired or drowsy?

Official regulatory lists of common side effects typically include drowsiness or fatigue as potential, though not certain or frequent, effects. It is recommended to review the full patient information leaflet for a comprehensive list of known reactions.

Q: What is the purpose of the 'inactive ingredients' in a Supramol tablet?

Inactive ingredients, also called excipients, are substances added during manufacturing that do not have a therapeutic effect themselves. They serve specific functions, such as giving the tablet its shape, color, or ensuring the active ingredient is properly absorbed by the body after ingestion.

Q: How quickly does Supramol start to work?

Official pharmacokinetic data indicates that the onset of action for oral forms is typically within 30 to 60 minutes after taking the dose. Peak concentrations in the blood, which correlate with the maximum effect, are usually reached within 90 minutes.

Q: How long does Supramol stay in your system?

The elimination half-life, which is the time it takes for half of the medicine to be removed from the bloodstream, is described in official documents as being approximately 1.5 to 2.5 hours in patients with normal liver function.

Q: Does Supramol contain any gluten or common allergens?

While the active ingredient (Acetaminophen) itself does not contain gluten, some specific brand formulations may use inactive ingredients (excipients) that contain trace elements or common allergens. Official regulatory information for the specific product being used is recommended to be checked for allergen warnings.

Q: Are there any special warnings for people with kidney problems using Supramol?

Yes. Regulatory documents state that for adults with severe renal impairment (a serious reduction in kidney function), the dose interval must be extended to, for example, every 8 hours instead of the usual 4 to 6 hours. Use requires caution in this population.

Q: Can Supramol cause weight changes?

Changes in body weight are not typically listed among the common or frequent adverse reactions in major regulatory documents. It is recommended to consult the full official patient information leaflet for a complete list of all known, documented side effects.

Q: What is the difference between Supramol and a generic version of the drug?

Supramol is the trade name given to the medicine, while the active ingredient is Acetaminophen/Paracetamol. A generic version contains the identical active ingredient and is required by regulatory agencies to be bioequivalent, meaning it works in the body the same way as the brand-name medicine.

Q: Does Supramol interact with birth control pills?

No significant interaction is generally documented. Regulatory information indicates that standard doses of this medicine do not reduce the contraceptive effectiveness of birth control pills. However, oral contraceptives may slightly decrease or delay the effects of this medicine.

Q: How soon after stopping Supramol will it be completely out of my body?

Based on its typical half-life of 1.5 to 2.5 hours, it generally takes about 5 to 6 half-lives for a medicine to be considered fully eliminated from the body. This means the medicine is usually eliminated within 12 to 15 hours after the last dose.

Q: Do I need a special diet while taking Supramol?

No special diet is typically required. However, regulatory documents warn that some specific formulations (like chewable tablets) may contain aspartame and carry a warning for individuals with Phenylketonuria (PKU), a condition that requires a special diet.

Q: Does Supramol cause sun sensitivity?

Sun sensitivity (photosensitivity) is not typically listed as a common or frequent adverse reaction in major regulatory documents. It is recommended to consult the full official patient information leaflet for a complete list of all known, documented side effects.

Q: Are headaches a common side effect of Supramol?

Headache is generally not listed as a common side effect of this medicine when used at recommended doses. Regulatory documents state the medicine is primarily used to treat mild pain, including headache.

Q: What happens if I accidentally take two doses of Supramol?

Taking two doses close together may exceed the recommended limit, which is officially discouraged due to the risk of liver damage. Regulatory documents emphasize the importance of seeking medical help immediately if a dose is exceeded or if an overdose is suspected, even if the individual feels well.

Q: Does Supramol cause any known problems with vision?

Official regulatory documents do not typically list vision problems as a common side effect. However, some nervous system effects, such as dizziness or drowsiness, may indirectly affect coordination or focus.

Q: Why is Supramol not recommended for certain age groups?

The medicine is not recommended for infants under 12 weeks of age without professional consultation. This restriction is because pediatric dosing is strictly based on body weight, and proper dosage calculation is critical to avoid toxicity in very young or small children.

Q: What kind of evidence supports the use of Supramol for its main purpose?

The medicine's purpose is supported by extensive evidence, including clinical recognition by numerous studies. Its importance is underscored by its inclusion on the World Health Organization's Model List of Essential Medicines, which highlights its indispensable role for pain and fever relief worldwide.

Q: Is Supramol considered a high-risk medication?

The regulatory classification can vary by region. While it is widely available over-the-counter, it is officially considered to be of high-risk potential in overdose due to the mandatory Boxed Warning regarding the risk of Acute Liver Failure.

Q: Can I split a Supramol tablet in half?

Official administration guidelines state that extended-release tablets must be swallowed whole. Splitting immediate-release tablets should only be considered if the tablet is officially scored (has a line) or if specific patient information states it can be split.

Q: Does taking Supramol affect blood test results?

Yes. Regulatory documents state that this medicine may interfere with the results of certain laboratory tests. This interference may specifically affect the determination of blood levels for uric acid and glucose.

Q: What is the difference between side effects and adverse reactions for Supramol?

In regulatory documents, both terms refer to unwanted effects. Side effects often describe known, secondary effects (both positive and negative), while adverse reactions refers to any unintended and potentially harmful response that is documented as being related to the drug.

Q: Is there a mandatory medication guide that comes with Supramol?

Yes. In certain jurisdictions, the manufacturer is required by regulatory law to provide a Mandatory Medication Guide for prescription products containing this medicine. This guide provides information intended to support the medicine's safe use.

How should Supramol be stored and disposed of?

How to Store and Dispose of Supramol

Storage of Supramol (Acetaminophen/Paracetamol) must strictly adhere to the conditions specified in official regulatory labeling to ensure product integrity.

Storage Requirement Official Regulatory Statement
Temperature Store below the maximum temperature specified (e.g., 25 C or 30 C). Do not refrigerate or freeze.
Protection Keep the product in the original container and protected from moisture and light.
Child Safety Must be stored out of the sight and reach of children.

Disposal Instructions

Unused or expired Supramol must be discarded according to local regulations for pharmaceutical waste, as advised by governmental health authorities. The product should not be disposed of in wastewater or household trash unless specifically instructed by local drug take-back programs.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Supramol found in:

A-Z Index: